Doing some more research today and the one thing that stood out from all else was....
Initially developed as a potential cancer drug, ISLA-101 has already been through 48 phase one and two clinical trials before being repurposed, and therefore offers Island Pharmaceuticals a much faster and cheaper path to commercialisation than traditional drug development routes.
very small MC IPO money going into clinical trials. and with some good results this will go quickly with small SOI with major shareholder holding 26%
with todays action might get a few peoples attention for tomorrows open
ILA Price at posting:
52.5¢ Sentiment: Buy Disclosure: Held
